PharmaTimes July 25, 2024
Jen Brogan

Conditions such as Alzheimer’s and Parkinson’s affect over one million people in the UK

Researchers from King’s College London (KCL), along with other collaborators, have found that ageing cells could reveal early signs of neurodegenerative diseases, including Alzheimer’s disease or amyotrophic lateral sclerosis.

Published in Aging Cell, the findings could provide a wider picture of a target area for drugs and could improve treatments for these types of conditions.

Affecting more than one million people in the UK, neurodegenerative conditions, such as multiple sclerosis and Parkinson’s disease, occur when cells of the central nervous system stop working or die.

Using fluorescence to measure the viscosity of neuronal cytoplasm, the fluid enclosed by the cell membrane of the neuron, in mice,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Survey / Study, Trends
Sanofi, expanding in radiopharma, strikes a joint venture deal
Sage to cut one-third of workforce, streamline drug pipeline
After rejections, AbbVie secures approval for Parkinson’s drug
Wave surges on first RNA editing data in humans
Lexicon sells Viatris rights to cardio drug outside of the U.S. and Europe

Share This Article